In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

The global clinical trials market has emerged as a vital cornerstone of the healthcare sector, driven by an ever-increasing ...

Teams must work together with technology solutions and optimize integration to unlock their full potential. Clinical trials ...

Market is on a rapid growth trajectory, poised to expand from USD 4.08 billion in 2024 to USD 10.35 billion by 2033, at a CAGR of 10.9% during the forecast period 2025–2033. This remarkable growth is ...

The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.

On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...

Researchers determined further improvements are necessary to better capture clinically useful data in a pediatric population for DOAC trials.

Multiracial growth impacts clinical trials. Explore challenges in race classification, health disparities, and genomic profiling.

Racial and ethnic minorities are underrepresented in DRCRnet DME trials, despite experiencing more severe symptoms than other ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...